{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T06:27:45Z","timestamp":1782628065930,"version":"3.54.5"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01864-2","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:25:54Z","timestamp":1779161154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u03b1-Synuclein as a molecular link between Parkinson\u2019s disease and chronic kidney disease: insights into the kidney-brain axis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1167-6642","authenticated-orcid":false,"given":"Shavinder","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2732-5230","authenticated-orcid":false,"given":"Nishant","family":"Goutam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3324-7298","authenticated-orcid":false,"given":"Vaishali","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9222-8818","authenticated-orcid":false,"given":"Shakshi","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3692-2774","authenticated-orcid":false,"given":"Shiv Kumar","family":"Kushawaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9140-4083","authenticated-orcid":false,"given":"Alka","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-426X","authenticated-orcid":false,"given":"Mahendra Singh","family":"Ashawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1033-0199","authenticated-orcid":false,"given":"Gaurav","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6814-331X","authenticated-orcid":false,"given":"Neeraj","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"1864_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12770-x","author":"M Alfaidi","year":"2024","unstructured":"Alfaidi M, Barker RA, Kuan WL (2024) An update on immune-based alpha-synuclein trials in Parkinson\u2019s disease. J Neurol. https:\/\/doi.org\/10.1007\/s00415-024-12770-x","journal-title":"J Neurol"},{"key":"1864_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.70721","author":"GH Alshehri","year":"2025","unstructured":"Alshehri GH, Al-kuraishy HM, Albuhadily AK, Al\u2010Gareeb AI, Aboutaleb AS, Alexiou A, Papadakis M, Batiha GE (2025) Differential roles of Angiotensin A and Alamandine in Parkinson\u2019s disease: a therapeutic perspective on nonclassical RAS pathways. Brain Behav. https:\/\/doi.org\/10.1002\/brb3.70721","journal-title":"Brain Behav"},{"key":"1864_CR3","doi-asserted-by":"publisher","first-page":"26978","DOI":"10.1074\/jbc.M111.249532","volume":"286","author":"DG Anderson","year":"2011","unstructured":"Anderson DG, Mariappan SVS, Buettner GR, Doorn JA (2011) Oxidation of 3,4-dihydroxyphenylacetaldehyde, a toxic dopaminergic metabolite, to a semiquinone radical and an ortho-quinone. J Biol Chem 286:26978\u201326986. https:\/\/doi.org\/10.1074\/jbc.M111.249532","journal-title":"J Biol Chem"},{"key":"1864_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mitoco.2024.03.002","volume":"2","author":"AK Aranda-Rivera","year":"2024","unstructured":"Aranda-Rivera AK, Cruz-Gregorio A, Amador-Mart\u00ednez I, Hern\u00e1ndez-Cruz EY, Tapia E, Pedraza-Chaverri J (2024) Antioxidants targeting mitochondria function in kidney diseases. Mitochondrial Commun 2:21\u201337. https:\/\/doi.org\/10.1016\/j.mitoco.2024.03.002","journal-title":"Mitochondrial Commun"},{"key":"1864_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"Bendor JT, Logan TP, Edwards RH (2013) The function of \u03b1-synuclein. Neuron 79. https:\/\/doi.org\/10.1016\/j.neuron.2013.09.004","journal-title":"Neuron"},{"key":"1864_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1369\/0022155419849388","volume":"67","author":"RD B\u00fclow","year":"2019","unstructured":"B\u00fclow RD, Boor P (2019) Extracellular matrix in kidney fibrosis: More than just a scaffold. J Histochem Cytochemistry 67:643\u2013661. https:\/\/doi.org\/10.1369\/0022155419849388","journal-title":"J Histochem Cytochemistry"},{"key":"1864_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15732-9","volume":"11","author":"M Bozic","year":"2020","unstructured":"Bozic M, Caus M, Rodrigues-Diez RR, Pedraza N, Ruiz-Ortega M, Gar\u00ed E, Gallel P, Panad\u00e9s MJ, Martinez A, Fern\u00e1ndez E, Valdivielso JM (2020) Protective role of renal proximal tubular alpha-synuclein in the pathogenesis of kidney fibrosis. Nat Commun 11:1943. https:\/\/doi.org\/10.1038\/s41467-020-15732-9","journal-title":"Nat Commun"},{"key":"1864_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz106.fp331","author":"M Bozic","year":"2019","unstructured":"Bozic M, Caus M, Rodrigues-Diez RR, Ruiz-Ortega M, Martinez A, Blasco A, Gallel P, Fernandez E, Valdivielso JM (2019) FP331alpha-synuclein maintains the epithelial phenotype and protects from renal fibrosis. Nephrol Dial Transpl. https:\/\/doi.org\/10.1093\/ndt\/gfz106.fp331","journal-title":"Nephrol Dial Transpl"},{"key":"1864_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JPD-150642","volume":"5","author":"J Burr\u00e9","year":"2015","unstructured":"Burr\u00e9 J (2015) The Synaptic Function of \u03b1-Synuclein. J Parkinsons Dis 5:699. https:\/\/doi.org\/10.3233\/JPD-150642","journal-title":"J Parkinsons Dis"},{"key":"1864_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14:176. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death Dis"},{"key":"1864_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00281-020-00819-8","volume":"42","author":"J Campos","year":"2020","unstructured":"Campos J, Pacheco R (2020) Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammation. Semin Immunopathol 42:681. https:\/\/doi.org\/10.1007\/s00281-020-00819-8","journal-title":"Semin Immunopathol"},{"key":"1864_CR13","doi-asserted-by":"publisher","first-page":"448166","DOI":"10.3389\/fnins.2019.00382","volume":"13","author":"A Canerina-Amaro","year":"2019","unstructured":"Canerina-Amaro A, Pereda D, Diaz M, Rodriguez-Barreto D, Casa\u00f1as-S\u00e1nchez V, Heffer M, Garcia-Esparcia P, Ferrer I, Puertas-Avenda\u00f1o R, Marin R (2019) Differential aggregation and phosphorylation of alpha synuclein in membrane compartments associated with Parkinson disease. Front Neurosci 13:448166. https:\/\/doi.org\/10.3389\/fnins.2019.00382","journal-title":"Front Neurosci"},{"key":"1864_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1899282","volume":"2022","author":"Y Cao","year":"2022","unstructured":"Cao Y, Shi Y, Wang Y, Yang Y, Guo W, Zhang C, Pei W, Fu C (2022) Exosomal hsa_circ_0008925 from urine is related to chronic renal fibrosis. Dis Markers 2022:1899282. https:\/\/doi.org\/10.1155\/2022\/1899282","journal-title":"Dis Markers"},{"key":"1864_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/0976500X241253648","volume":"15","author":"J Chand","year":"2024","unstructured":"Chand J, Fanai HL, Antony AS, Subramanian G (2024) Neurotoxicity by hypoxia an intermediate between alpha-synuclein and mitochondrial dysfunction in Parkinson\u2019s disease. J Pharmacol Pharmacother 15:253\u2013263. https:\/\/doi.org\/10.1177\/0976500X241253648","journal-title":"J Pharmacol Pharmacother"},{"key":"1864_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1021\/acs.molpharmaceut.2c00548","volume":"20","author":"S Chia","year":"2023","unstructured":"Chia S, Faidon Brotzakis Z, Horne RI, Possenti A, Mannini B, Cataldi R, Nowinska M, Staats R, Linse S, Knowles TPJ, Habchi J, Vendruscolo M (2023) Structure-based discovery of small-molecule inhibitors of the autocatalytic proliferation of \u03b1-synuclein aggregates. Mol Pharm 20:183\u2013193. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.2c00548","journal-title":"Mol Pharm"},{"key":"1864_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4103\/1735-1995.181989","volume":"21","author":"FN Emamzadeh","year":"2016","unstructured":"Emamzadeh FN (2016) Alpha-synuclein structure, functions, and interactions. J Res Med Sci 21:29. https:\/\/doi.org\/10.4103\/1735-1995.181989","journal-title":"J Res Med Sci"},{"key":"1864_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/j.1582-4934.2008.00281.x","volume":"12","author":"PV Escrib\u00e1","year":"2008","unstructured":"Escrib\u00e1 PV, Gonz\u00e1lez-Ros JM, Go\u00f1i FM, Kinnunen PKJ, Vigh L, S\u00e1nchez-Magraner L, Fern\u00e1ndez AM, Busquets X, Horv\u00e1th I, Barcel\u00f3-Coblijn G (2008) Membranes: a meeting point for lipids, proteins and therapies. J Cell Mol Med 12:829. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00281.x","journal-title":"J Cell Mol Med"},{"key":"1864_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01690-9","author":"L Franck","year":"2025","unstructured":"Franck L, Valek L, Hahnefeld L, Trautmann S, Angioni C, Weyer MP, Thomas D, Gurke R, Wittig I, Geisslinger G, Tegeder I (2025) Modest improvement of metabolic and behavioral deficits with long-term ambroxol treatment in a Pink1-\/-SNCAA53T double mutant mouse model of Parkinson\u2019s disease. Acta Pharmacol Sin. https:\/\/doi.org\/10.1038\/s41401-025-01690-9","journal-title":"Acta Pharmacol Sin"},{"key":"1864_CR20","doi-asserted-by":"publisher","DOI":"10.4331\/wjbc.v9.i1.1","volume":"9","author":"J Fujii","year":"2018","unstructured":"Fujii J, Homma T, Kobayashi S, Seo HG (2018) Mutual interaction between oxidative stress and endoplasmic reticulum stress in the pathogenesis of diseases specifically focusing on non-alcoholic fatty liver disease. World J Biol Chem 9:1. https:\/\/doi.org\/10.4331\/wjbc.v9.i1.1","journal-title":"World J Biol Chem"},{"key":"1864_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.885500","volume":"14","author":"X-Y Gao","year":"2022","unstructured":"Gao XY, Yang T, Gu Y, Sun XH (2022) Mitochondrial dysfunction in Parkinson\u2019s disease: from mechanistic insights to therapy. Front Aging Neurosci 14:885500. https:\/\/doi.org\/10.3389\/fnagi.2022.885500","journal-title":"Front Aging Neurosci"},{"key":"1864_CR103","doi-asserted-by":"publisher","unstructured":"Gautam D, Naik UP, Naik MU, Yadav SK, Chaurasia RN, Dash D (2023) Glutamate receptor dysregulation and platelet glutamate dynamics in Alzheimer's and Parkinson's diseases: Insights into current medications. Biomolecules 13(11):1609. https:\/\/doi.org\/10.3390\/biom13111609","DOI":"10.3390\/biom13111609"},{"key":"1864_CR23","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/brain\/awac096","volume":"145","author":"E Giacobini","year":"2022","unstructured":"Giacobini E, Cuello AC, Fisher A (2022) Reimagining cholinergic therapy for Alzheimer\u2019s disease. Brain 145:2250\u20132275. https:\/\/doi.org\/10.1093\/brain\/awac096","journal-title":"Brain"},{"key":"1864_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/17562864251339895","author":"L Guan","year":"2025","unstructured":"Guan L, Lin L, Ma C, Qiu L (2025) Decoding crosstalk between neurotransmitters and \u03b1-synuclein in Parkinson\u2019s disease: pathogenesis and therapeutic implications. Ther Adv Neurol Disord. https:\/\/doi.org\/10.1177\/17562864251339895","journal-title":"Ther Adv Neurol Disord"},{"key":"1864_CR25","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41380-021-01296-7","volume":"27","author":"Y-J Guo","year":"2022","unstructured":"Guo YJ, Xiong H, Chen K, Zou JJ, Lei P (2022) Brain regions susceptible to alpha-synuclein spreading. Mol Psychiatry 27:758\u2013770. https:\/\/doi.org\/10.1038\/s41380-021-01296-7","journal-title":"Mol Psychiatry"},{"key":"1864_CR101","doi-asserted-by":"publisher","unstructured":"Han D, Zheng W, Wang X, Chen Z (2020) Proteostasis of \u03b1-Synuclein and Its Role in the Pathogenesis of Parkinson's Disease. Front Cell Neurosci 14:45. https:\/\/doi.org\/10.3389\/fncel.2020.00045","DOI":"10.3389\/fncel.2020.00045"},{"key":"1864_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00368-6","volume":"15","author":"BA Hijaz","year":"2020","unstructured":"Hijaz BA, Volpicelli-Daley LA (2020) Initiation and propagation of \u03b1-synuclein aggregation in the nervous system. Mol Neurodegener 15:19. https:\/\/doi.org\/10.1186\/s13024-020-00368-6","journal-title":"Mol Neurodegener"},{"key":"1864_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010088","volume":"12","author":"HJ Ho","year":"2022","unstructured":"Ho HJ, Shirakawa H (2022) Oxidative stress and mitochondrial dysfunction in chronic kidney disease. Cells 12:12. https:\/\/doi.org\/10.3390\/cells12010088","journal-title":"Cells"},{"key":"1864_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad356","author":"A Houldsworth","year":"2024","unstructured":"Houldsworth A (2024) Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcad356","journal-title":"Brain Commun"},{"issue":"22","key":"1864_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22052298","volume":"22","author":"CN Hsu","year":"2021","unstructured":"Hsu CN, Tain YL (2021) Targeting the Renin\u2013Angiotensin\u2013Aldosterone System to prevent hypertension and kidney disease of developmental origins. Int J Mol Sci 22(22):1\u201323. https:\/\/doi.org\/10.3390\/ijms22052298","journal-title":"Int J Mol Sci"},{"key":"1864_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","volume":"157","author":"LJ Hsu","year":"2000","unstructured":"Hsu LJ, Sagara Y, Arroyo A et al (2000) \u03b1-Synuclein promotes mitochondrial deficit and oxidative stress. The American Journal of Pathology 157:401\u2013410.https:\/\/doi.org\/10.1016\/S0002-9440(10)64553-1","journal-title":"Am J Pathol"},{"key":"1864_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2174\/1570159X16666180302115032","volume":"17","author":"S Jamwal","year":"2019","unstructured":"Jamwal S, Kumar P (2019) Insight into the emerging role of striatal neurotransmitters in the pathophysiology of Parkinson\u2019s disease and Huntington\u2019s disease: a review. Curr Neuropharmacol 17:165\u2013175. https:\/\/doi.org\/10.2174\/1570159X16666180302115032","journal-title":"Curr Neuropharmacol"},{"key":"1864_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1124\/PHARMREV.120.000133","volume":"74","author":"HG Jasutkar","year":"2022","unstructured":"Jasutkar HG, Oh SE, Mouradian MM (2022) Therapeutics in the pipeline targeting \u03b1-Synuclein for Parkinson\u2019s disease. Pharmacol Rev 74:207\u2013237. https:\/\/doi.org\/10.1124\/PHARMREV.120.000133","journal-title":"Pharmacol Rev"},{"key":"1864_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103399","volume":"77","author":"J Jiao","year":"2024","unstructured":"Jiao J, Gao G, Zhu J, Wang C, Liu L, Yang H (2024) Binding of \u03b1-synuclein to ACO2 promotes progressive mitochondrial dysfunction in Parkinson\u2019s disease models. Redox Biol 77. https:\/\/doi.org\/10.1016\/j.redox.2024.103399","journal-title":"Redox Biol"},{"key":"1864_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.562241","volume":"8","author":"M Kiechle","year":"2020","unstructured":"Kiechle M, Grozdanov V, Danzer KM (2020) The role of lipids in the initiation of \u03b1-Synuclein misfolding. Front Cell Dev Biol 8. https:\/\/doi.org\/10.3389\/fcell.2020.562241","journal-title":"Front Cell Dev Biol"},{"key":"1864_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121813","volume":"11","author":"B Kosmowska","year":"2021","unstructured":"Kosmowska B, Wardas J (2021) The pathophysiology and treatment of Essential Tremor: the role of adenosine and dopamine receptors in animal models. Biomolecules 11:1813. https:\/\/doi.org\/10.3390\/biom11121813","journal-title":"Biomolecules"},{"key":"1864_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cbi.2008.04.004","volume":"175","author":"S Kotani","year":"2008","unstructured":"Kotani S, Yamauchi T, Teramoto T, Ogura H (2008) Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis. Chem Biol Interact 175:227\u2013230. https:\/\/doi.org\/10.1016\/j.cbi.2008.04.004","journal-title":"Chem Biol Interact"},{"key":"1864_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158132","volume":"25","author":"D Krawczuk","year":"2024","unstructured":"Krawczuk D, Kulczy\u0144ska-Przybik A, Mroczko B (2024) Clinical application of blood biomarkers in neurodegenerative diseases\u2014present and future perspectives. Int J Mol Sci 25:25. https:\/\/doi.org\/10.3390\/ijms25158132","journal-title":"Int J Mol Sci"},{"key":"1864_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2014.00067","volume":"8","author":"JL Labandeira-Garc\u00eda","year":"2014","unstructured":"Labandeira-Garc\u00eda JL, Garrido-Gil P, Rodriguez-Pallares J, Valenzuela R, Borrajo A, Rodr\u00edguez-Perez AI (2014) Brain renin-angiotensin system and dopaminergic cell vulnerability. Front Neuroanat 8:103074. https:\/\/doi.org\/10.3389\/fnana.2014.00067","journal-title":"Front Neuroanat"},{"key":"1864_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.osep.2025.10.001","author":"CM Lepkowsky","year":"2025","unstructured":"Lepkowsky CM (2025) Kidney impairment and \u03b1-Synucleinopathy: implications for assessment and treatment. Am J Geriatr Psychiatry. https:\/\/doi.org\/10.1016\/j.osep.2025.10.001","journal-title":"Am J Geriatr Psychiatry"},{"key":"1864_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120092","volume":"287","author":"J Li","year":"2021","unstructured":"Li J, Jin S, Barati MT, Rane S, Lin Q, Tan Y, Cai L, Rane MJ (2021) ERK and p38 MAPK inhibition controls NF-E2 degradation and profibrotic signaling in renal proximal tubule cells. Life Sci 287. https:\/\/doi.org\/10.1016\/j.lfs.2021.120092","journal-title":"Life Sci"},{"key":"1864_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212114","volume":"25","author":"SC Lin","year":"2024","unstructured":"Lin SC, Chang CC, Tsou SH, Chiu PY, Cheng JF, Hung HC, Chen WJ, Ho YJ, Lin CL (2024) Protective effects of Ambroxol on A\u03b2 and \u03b1-Synuclein-induced neurotoxicity through glucocerebrosidase activation in HT-22 hippocampal neuronal cells. Int J Mol Sci 25:25. https:\/\/doi.org\/10.3390\/ijms252212114","journal-title":"Int J Mol Sci"},{"key":"1864_CR43","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.semnuclmed.2025.03.008","volume":"55","author":"W Lin","year":"2025","unstructured":"Lin W, Huang C, Tan Z, Xu H, Wei W, Wang L (2025) CuII-bis(thioureido) complex: a potential radiotracer for detecting oxidative stress and neuroinflammation in neurodegenerative diseases. Semin Nucl Med 55:577\u2013586. https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.03.008","journal-title":"Semin Nucl Med"},{"key":"1864_CR41","doi-asserted-by":"publisher","DOI":"10.7150\/thno.100080","volume":"14","author":"S Li","year":"2024","unstructured":"Li S, Zhang G, Hu J, Tian Y, Fu X (2024) Ferroptosis at the nexus of metabolism and metabolic diseases. Theranostics 14:5826. https:\/\/doi.org\/10.7150\/thno.100080","journal-title":"Theranostics"},{"key":"1864_CR44","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.1021\/acs.analchem.0c00338","volume":"92","author":"KH Liu","year":"2020","unstructured":"Liu KH, Nellis M, Uppal K, Ma C, Tran VL, Liang Y, Walker DI, Jones DP (2020) Reference standardization for quantification and harmonization of large-scale metabolomics. Anal Chem 92:8836\u20138844. https:\/\/doi.org\/10.1021\/acs.analchem.0c00338","journal-title":"Anal Chem"},{"key":"1864_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010141","volume":"20","author":"F Longhena","year":"2019","unstructured":"Longhena F, Faustini G, Spillantini MG, Bellucci A (2019) Living in promiscuity: the multiple partners of Alpha-Synuclein at the synapse in physiology and pathology. Int J Mol Sci 20:141. https:\/\/doi.org\/10.3390\/ijms20010141","journal-title":"Int J Mol Sci"},{"key":"1864_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.70237","volume":"62","author":"Z Lu","year":"2025","unstructured":"Lu Z, Yin H, Xiang P, Yi X, Tian X, Gong Q (2025) Multimodal imaging of blood\u2013brain barrier dysfunction in Parkinson\u2019s disease: from pathological mechanisms to therapeutic opportunities. Eur J Neurosci 62:e70237. https:\/\/doi.org\/10.1111\/ejn.70237","journal-title":"Eur J Neurosci"},{"key":"1864_CR47","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1021\/jacsau.3c00579","volume":"4","author":"K Makasewicz","year":"2024","unstructured":"Makasewicz K, Linse S, Sparr E (2024) Interplay of \u03b1-synuclein with lipid membranes: cooperative adsorption, membrane remodeling and coaggregation. JACS Au 4:1250\u20131262. https:\/\/doi.org\/10.1021\/jacsau.3c00579","journal-title":"JACS Au"},{"key":"1864_CR48","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/brain\/awu020","volume":"137","author":"A McNeill","year":"2014","unstructured":"McNeill A, Magalhaes J, Shen C, Chau KY, Hughes D, Mehta A, Foltynie T, Cooper JM, Abramov AY, Gegg M, Schapira AHV (2014) Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells. Brain 137:1481. https:\/\/doi.org\/10.1093\/brain\/awu020","journal-title":"Brain"},{"key":"1864_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.852003","volume":"13","author":"S Menon","year":"2022","unstructured":"Menon S, Armstrong S, Hamzeh A, Visanji NP, Sardi SP, Tandon A (2022) Alpha-Synuclein targeting therapeutics for Parkinson\u2019s Disease and related synucleinopathies. Front Neurol 13. https:\/\/doi.org\/10.3389\/fneur.2022.852003","journal-title":"Front Neurol"},{"key":"1864_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.nbd.2018.01.004","volume":"112","author":"G Mercado","year":"2018","unstructured":"Mercado G, Castillo V, Soto P, L\u00f3pez N, Axten JM, Sardi SP, Hoozemans JJM, Hetz C (2018) Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson\u2019s disease. Neurobiol Dis 112:136\u2013148. https:\/\/doi.org\/10.1016\/j.nbd.2018.01.004","journal-title":"Neurobiol Dis"},{"key":"1864_CR100","doi-asserted-by":"publisher","unstructured":"\u00dcnal Y, Akba\u015f D, \u00d6zdemir \u00c7, Edg\u00fcnl\u00fc T (2026) Dysregulated MicroRNAs in Parkinson's Disease: Pathogenic Mechanisms and Biomarker Potential. Int J Mol Sci 27(2):930. https:\/\/doi.org\/10.3390\/ijms27020930","DOI":"10.3390\/ijms27020930"},{"key":"1864_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/mds.70138","author":"TF Outeiro","year":"2025","unstructured":"Outeiro TF, Koss DJ (2025) Nuclear alpha-synuclein: mechanisms and implications for synucleinopathies. Mov Disord. https:\/\/doi.org\/10.1002\/mds.70138","journal-title":"Mov Disord"},{"key":"1864_CR52","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000533502","volume":"3","author":"MV Pahl","year":"2023","unstructured":"Pahl MV, Hou J (2023) Fabry disease presenting as end-stage kidney disease. Glomerular Dis 3:189. https:\/\/doi.org\/10.1159\/000533502","journal-title":"Glomerular Dis"},{"key":"1864_CR104","doi-asserted-by":"publisher","unstructured":"Parkinson\u2019s Disease (2025) Mov Disord 40:S413\u2013S1072. https:\/\/doi.org\/10.1002\/mds.30318","DOI":"10.1002\/mds.30318"},{"key":"1864_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/hmg\/ddy326","volume":"28","author":"R Pinho","year":"2019","unstructured":"Pinho R, Paiva I, Jer\u010di\u0107 KG, Fonseca-Ornelas L, Gerhardt E, Fahlbusch C, Garcia-Esparcia P, Kerimoglu C, Pavlou MAS, Villar-Piqu\u00e9 A, Szeg\u0151 \u00c9, Lopes da Fonseca T, Odoardi F, Soeroes S, Rego AC, Fischle W, Schwamborn JC, Meyer T, K\u00fcgler S, Ferrer I, Attems J, Fischer A, Becker S, Zweckstetter M, Borovecki F, Outeiro TF (2019) Nuclear localization and phosphorylation modulate pathological effects of alpha-synuclein. Hum Mol Genet 28:31\u201350. https:\/\/doi.org\/10.1093\/hmg\/ddy326","journal-title":"Hum Mol Genet"},{"key":"1864_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15121260","volume":"15","author":"J Pitton Rissardo","year":"2025","unstructured":"Pitton Rissardo J, McGarry A, Shi Y, Fornari Caprara AL, Kannarkat GT (2025) Alpha-synuclein neurobiology in Parkinson\u2019s Disease: a comprehensive review of its role, mechanisms, and therapeutic perspectives. Brain Sci 15:15. https:\/\/doi.org\/10.3390\/brainsci15121260","journal-title":"Brain Sci"},{"key":"1864_CR99","doi-asserted-by":"publisher","unstructured":"Praveen A, Dougnon G, Matsui H (2025) Exploring \u03b1-Syn's Functions Through Ablation Models: Physiological and Pathological Implications. Cell Mol Neurobiol 45(1):44. https:\/\/doi.org\/10.1007\/s10571-025-01560-2","DOI":"10.1007\/s10571-025-01560-2"},{"key":"1864_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14080975","volume":"14","author":"MM Quetglas-Llabr\u00e9s","year":"2025","unstructured":"Quetglas-Llabr\u00e9s MM, D\u00edaz-L\u00f3pez A, Bouzas C, Monserrat-Mesquida M, Salas-Salvad\u00f3 J, Ruiz-Canela M, Mart\u00ednez JA, Santos-Lozano JM, Garc\u00eda S, Estruch R, L\u00f3pez-Miranda J, Romaguera D, Tinahones FJ, Garc\u00eda-Fern\u00e1ndez M, Mas-Fontao S, Mat\u00eda-Mart\u00edn P, Vioque J, Bueno A, Babio N, Tur JA, Sureda A (2025) Association between oxidative\u2013inflammation biomarkers and incident chronic kidney disease in people with high cardiovascular risk: a nested case\u2013control study. Antioxidants (Basel) 14:975. https:\/\/doi.org\/10.3390\/antiox14080975","journal-title":"Antioxidants (Basel)"},{"key":"1864_CR57","doi-asserted-by":"publisher","unstructured":"Radad K, Moldzio R, Krewenka C, Kranner B, Rausch W-D (2023) Pathophysiology of non-motor signs in Parkinson\u2019s disease: some recent updating with brief presentation. Explor Neuroprotective Therapy 24\u201346. https:\/\/doi.org\/10.37349\/ent.2023.00036","DOI":"10.37349\/ent.2023.00036"},{"key":"1864_CR58","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.jval.2025.08.008","volume":"28","author":"S Randhawa","year":"2025","unstructured":"Randhawa S, Gater A, Bentley R (2025) Patient-reported outcomes now and into the future: multistakeholder perspectives on optimizing the use of patient-reported outcome evidence in decision making across the US healthcare continuum. Value Health 28:1868\u20131880. https:\/\/doi.org\/10.1016\/j.jval.2025.08.008","journal-title":"Value Health"},{"key":"1864_CR59","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1021\/tx9000557","volume":"22","author":"JN Rees","year":"2009","unstructured":"Rees JN, Florang VR, Eckert LL, Doorn JA (2009) Protein reactivity of 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite, is dependent on both the aldehyde and the catechol. Chem Res Toxicol 22:1256\u20131263. https:\/\/doi.org\/10.1021\/tx9000557","journal-title":"Chem Res Toxicol"},{"key":"1864_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36470","volume":"10","author":"J Ren","year":"2024","unstructured":"Ren J, Xiang B, Xueling L, Han X, Yang Z, Zhang M, Zhang Y (2024) Molecular mechanisms of mitochondrial homeostasis regulation in neurons and possible therapeutic approaches for Alzheimer\u2019s disease. Heliyon 10:e36470. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e36470","journal-title":"Heliyon"},{"key":"1864_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/biom11050718","volume":"11","author":"P Risiglione","year":"2021","unstructured":"Risiglione P, Zinghirino F, Di Rosa MC, Magr\u00ec A, Messina A (2021) Alpha-synuclein and mitochondrial dysfunction in Parkinson\u2019s Disease: the emerging role of VDAC. Biomolecules 11:718. https:\/\/doi.org\/10.3390\/biom11050718","journal-title":"Biomolecules"},{"key":"1864_CR62","doi-asserted-by":"publisher","first-page":"13176","DOI":"10.1073\/pnas.1704351114","volume":"114","author":"R Rott","year":"2017","unstructured":"Rott R, Szargel R, Shani V, Hamza H, Savyon M, Elghani FA, Bandopadhyay R, Engelender S (2017) SUMOylation and ubiquitination reciprocally regulate \u03b1-synuclein degradation and pathological aggregation. Proc Natl Acad Sci USA 114:13176\u201313181. https:\/\/doi.org\/10.1073\/pnas.1704351114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1864_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/biom14121649","volume":"14","author":"L Shen","year":"2024","unstructured":"Shen L, Dettmer U (2024) Alpha-synuclein effects on mitochondrial quality control in Parkinson\u2019s Disease. Biomolecules 14:1649. https:\/\/doi.org\/10.3390\/biom14121649","journal-title":"Biomolecules"},{"key":"1864_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082051","volume":"15","author":"N Siwecka","year":"2023","unstructured":"Siwecka N, Saramowicz K, Galita G, Rozp\u0119dek-Kami\u0144ska W, Majsterek I (2023a) Inhibition of protein aggregation and endoplasmic reticulum stress as a targeted therapy for \u03b1-Synucleinopathy. Pharmaceutics 15:2051. https:\/\/doi.org\/10.3390\/pharmaceutics15082051","journal-title":"Pharmaceutics"},{"key":"1864_CR67","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.REV118.006493","volume":"294","author":"D Snead","year":"2019","unstructured":"Snead D, Eliezer D (2019) Intrinsically disordered proteins in synaptic vesicle trafficking and release. J Biol Chem 294:3325. https:\/\/doi.org\/10.1074\/jbc.REV118.006493","journal-title":"J Biol Chem"},{"key":"1864_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/genes12081166","volume":"12","author":"M Somayaji","year":"2021","unstructured":"Somayaji M, Lanseur Z, Choi SJ, Sulzer D, Mosharov EV (2021) Roles for \u03b1-synuclein in gene expression. Genes Basel 12:1166. https:\/\/doi.org\/10.3390\/genes12081166","journal-title":"Genes Basel"},{"key":"1864_CR69","doi-asserted-by":"publisher","unstructured":"Srinivasan E, Chandrasekhar G, Chandrasekar P, Anbarasu K, Vickram AS, Karunakaran R, Rajasekaran R, Srikumar PS (2021a) Alpha-Synuclein Aggregation in Parkinson\u2019s Disease. Front Med Lausanne 8. https:\/\/doi.org\/10.3389\/fmed.2021.736978","DOI":"10.3389\/fmed.2021.736978"},{"key":"1864_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26020806","author":"AM Stanigut","year":"2025","unstructured":"Stanigut AM, Tuta L, Pana C, Alexandrescu L, Suceveanu A, Blebea NM, Vacaroiu IA (2025) Autophagy and Mitophagy in Diabetic Kidney Disease-A Literature Review. Int J Mol Sci 26(2):806. https:\/\/doi.org\/10.3390\/ijms26020806","journal-title":"Int. J. Mol. Sci."},{"key":"1864_CR71","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L (2012) \u03b1-synuclein in Parkinson\u2019s Disease. Cold Spring Harb Perspect Med 2:a009399. https:\/\/doi.org\/10.1101\/cshperspect.a009399","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1864_CR72","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/jnc.14704","volume":"150","author":"L Stefanis","year":"2019","unstructured":"Stefanis L, Emmanouilidou E, Pantazopoulou M, Kirik D, Vekrellis K, Tofaris GK (2019) How is alpha-synuclein cleared from the cell? J Neurochem 150:577\u2013590. https:\/\/doi.org\/10.1111\/jnc.14704","journal-title":"J Neurochem"},{"key":"1864_CR73","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/jnc.14810","volume":"150","author":"D Sulzer","year":"2019","unstructured":"Sulzer D, Edwards RH (2019) The physiological role of \u03b1-synuclein and its relationship to Parkinson\u2019s Disease. J Neurochem 150:475\u2013486. https:\/\/doi.org\/10.1111\/jnc.14810","journal-title":"J Neurochem"},{"key":"1864_CR74","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1111\/febs.17072","volume":"291","author":"A Surguchov","year":"2024","unstructured":"Surguchov A (2024) Nuclear \u03b1-synuclein regulates transcription and affects neuronal differentiation. FEBS J 291:1886\u20131888. https:\/\/doi.org\/10.1111\/febs.17072","journal-title":"FEBS J"},{"key":"1864_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1034072","author":"V Suvarna","year":"2022","unstructured":"Suvarna V, Deshmukh K, Murahari M (2022) miRNA and antisense oligonucleotide-based \u03b1-synuclein targeting as disease-modifying therapeutics in Parkinson\u2019s disease. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1034072","journal-title":"Front Pharmacol"},{"key":"1864_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-021-02695-1","volume":"59","author":"DF Tardiff","year":"2022","unstructured":"Tardiff DF, Lucas M, Wrona I, Chang B, Chung CY, Le Bourdonnec B, Rhodes KJ, Scannevin RH (2022) Non-clinical pharmacology of YTX-7739: a clinical stage stearoyl-CoA desaturase inhibitor being developed for Parkinson\u2019s Disease. Mol Neurobiol 59:2171. https:\/\/doi.org\/10.1007\/s12035-021-02695-1","journal-title":"Mol Neurobiol"},{"key":"1864_CR77","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.3390\/ijms23115954","volume":"23","author":"RI Teleanu","year":"2022","unstructured":"Teleanu RI, Niculescu A-G, Roza E, Vlad\u00e2cenco O, Grumezescu AM, Teleanu DM (2022) Neurotransmitters\u2014key factors in neurological and neurodegenerative disorders of the Central Nervous System. Int J Mol Sci 23:5954. https:\/\/doi.org\/10.3390\/ijms23115954","journal-title":"Int J Mol Sci"},{"key":"1864_CR78","doi-asserted-by":"publisher","first-page":"197722","DOI":"10.3389\/fnins.2016.00205","volume":"10","author":"M Unzeta","year":"2016","unstructured":"Unzeta M, Esteban G, Bolea I, Fogel WA, Ramsay RR, Youdim MBH, Tipton KF, Marco-Contelles J (2016) Multi-target directed donepezil-like ligands for Alzheimer\u2019s disease. Front Neurosci 10:197722. https:\/\/doi.org\/10.3389\/fnins.2016.00205","journal-title":"Front Neurosci"},{"key":"1864_CR79","doi-asserted-by":"publisher","first-page":"102988","DOI":"10.1016\/j.eclinm.2024.102988","volume":"79","author":"M Ursino","year":"2025","unstructured":"Ursino M, Villacampa G, Rekowski J, Dimairo M, Solovyeva O, Ashby D, Berlin J, Boix O, Calvert M, Chan AW, Coschi CH, Evans TRJ, Garrett-Mayer E, Golub RM, Guo C, Hayward KS, Hopewell S, Isaacs JD, Ivy SP, Jaki T, Kholmanskikh O, Kightley A, Lee S, Liu R, Mander A, Marshall LV, Matcham J, Patel D, Peck R, Rantell KR, Richards DP, Rouhifard M, Seymour L, Tanaka Y, Weir CJ, de Bono J, Yap C (2025) SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols. EClinicalMedicine 79:102988. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102988","journal-title":"EClinicalMedicine"},{"key":"1864_CR80","doi-asserted-by":"publisher","first-page":"253","DOI":"10.15698\/cst2018.10.158","volume":"2","author":"AM Valera","year":"2018","unstructured":"Valera AM, Canto C (2018) Mitochondrial stress management: a dynamic journey. Cell Stress 2:253. https:\/\/doi.org\/10.15698\/cst2018.10.158","journal-title":"Cell Stress"},{"key":"1864_CR81","doi-asserted-by":"publisher","first-page":"183","DOI":"10.23876\/j.krcp.20.163","volume":"40","author":"S Verma","year":"2021","unstructured":"Verma S, Singh P, Khurana S, Ganguly NK, Kukreti R, Saso L, Rana DS, Taneja V, Bhargava V (2021) Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies. Kidney Res Clin Pract 40:183. https:\/\/doi.org\/10.23876\/j.krcp.20.163","journal-title":"Kidney Res Clin Pract"},{"key":"1864_CR82","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3390\/cells11111732","volume":"11","author":"M Vidovi\u0107","year":"2022","unstructured":"Vidovi\u0107 M, Rikalovic MG (2022) Alpha-Synuclein Aggregation Pathway in Parkinson\u2019s Disease: Current Status and Novel Therapeutic Approaches. Cells 11:1732. https:\/\/doi.org\/10.3390\/cells11111732","journal-title":"Cells"},{"key":"1864_CR83","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22179290","volume":"22","author":"\u0141J Walczak-Nowicka","year":"2021","unstructured":"Walczak-Nowicka \u0141J, Herbet M (2021) Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis. Int J Mol Sci 22:22. https:\/\/doi.org\/10.3390\/ijms22179290","journal-title":"Int J Mol Sci 2021"},{"key":"1864_CR84","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1039\/d4bm00881b","volume":"12","author":"Q Wang","year":"2024","unstructured":"Wang Q, Nie X, Song Y, Qiu H, Chen L, Zhu H, Zhang X, Yang M, Xu X, Chen P, Zhang C, Xu J, Ren Y, Shang W (2024) Redox nanodrugs alleviate chronic kidney disease by reducing inflammation and regulating ROS. Biomater Sci 12:6403\u20136415. https:\/\/doi.org\/10.1039\/d4bm00881b","journal-title":"Biomater Sci"},{"key":"1864_CR85","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3233\/JPD-202076","volume":"10","author":"CL West","year":"2020","unstructured":"West CL, Mao YK, Delungahawatta T, Amin JY, Farhin S, McQuade RM, DIwakarla S, Pustovit R, Stanisz AM, Bienenstock J, Barbut D, Zasloff M, Furness JB, Kunze WA (2020) Squalamine restores the function of the enteric nervous system in mouse models of Parkinson\u2019s Disease. J Parkinsons Dis 10:1477\u20131491. https:\/\/doi.org\/10.3233\/JPD-202076","journal-title":"J Parkinsons Dis"},{"key":"1864_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312778","volume":"22","author":"P Whitley","year":"2021","unstructured":"Whitley P, Grau B, Gumbart JC, Mart\u00ednez-Gil L, Mingarro I (2021) Folding and insertion of transmembrane helices at the ER. Int J Mol Sci 22:12778. https:\/\/doi.org\/10.3390\/ijms222312778","journal-title":"Int J Mol Sci"},{"key":"1864_CR87","doi-asserted-by":"publisher","first-page":"F38","DOI":"10.1152\/ajprenal.00425.2021","volume":"325","author":"SS Wildman","year":"2023","unstructured":"Wildman SS, Dunn K, Van Beusecum JP, Inscho EW, Kelley S, Lilley RJ, Cook AK, Taylor KD, Peppiatt-Wildman CM (2023) A novel functional role for the classic CNS neurotransmitters, GABA, glycine, and glutamate, in the kidney: potent and opposing regulators of the renal vasculature. Am J Physiol Renal Physiol 325:F38\u2013F49. https:\/\/doi.org\/10.1152\/ajprenal.00425.2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"1864_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1470171","volume":"17","author":"S Wu","year":"2024","unstructured":"Wu S, Schekman RW (2024) Intercellular transmission of alpha-synuclein. Front Mol Neurosci 17:1470171. https:\/\/doi.org\/10.3389\/fnmol.2024.1470171","journal-title":"Front Mol Neurosci"},{"key":"1864_CR89","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","volume":"10","author":"X Xu","year":"2025","unstructured":"Xu X, Pang Y, Fan X (2025) Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Signal Transduct Target Ther 10:190. https:\/\/doi.org\/10.1038\/s41392-025-02253-4","journal-title":"Signal Transduct Target Ther"},{"key":"1864_CR90","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.4103\/1673-5374.387967","volume":"19","author":"Y Yang","year":"2024","unstructured":"Yang Y, Zhang Z (2024) \u03b1-Synuclein pathology from the body to the brain: so many seeds so close to the central soil. Neural Regen Res 19:1463\u20131472. https:\/\/doi.org\/10.4103\/1673-5374.387967","journal-title":"Neural Regen Res"},{"key":"1864_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03043-5","author":"BC Yildirim","year":"2024","unstructured":"Yildirim BC, Fenyi A, Besnault P, Gomez L, Sepulveda-Diaz JE, Michel PP, Melki R, Hunot S (2024) Parkinson\u2019s disease-derived \u03b1-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype. J Neuroinflammation. https:\/\/doi.org\/10.1186\/s12974-024-03043-5","journal-title":"J Neuroinflammation"},{"key":"1864_CR92","doi-asserted-by":"publisher","first-page":"323","DOI":"10.5483\/BMBRep.2022.55.7.073","volume":"55","author":"H Yoo","year":"2022","unstructured":"Yoo H, Lee J, Kim B, Moon H, Jeong H, Lee K, Song WJ, Hur JK, Oh Y (2022) Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson\u2019s disease. BMB Rep 55:323\u2013335. https:\/\/doi.org\/10.5483\/BMBRep.2022.55.7.073","journal-title":"BMB Rep"},{"key":"1864_CR93","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C (2022) Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther 7:182. https:\/\/doi.org\/10.1038\/s41392-022-01036-5","journal-title":"Signal Transduct Target Ther"},{"key":"1864_CR94","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41593-024-01866-2","volume":"28","author":"X Yuan","year":"2025","unstructured":"Yuan X, Nie S, Yang Y, Liu C, Xia D, Meng L, Xia Y, Su H, Zhang C, Bu L, Deng M, Ye K, Xiong J, Chen L, Zhang Z (2025a) Propagation of pathologic \u03b1-synuclein from kidney to brain may contribute to Parkinson\u2019s disease. Nat Neurosci 28:577\u2013588. https:\/\/doi.org\/10.1038\/s41593-024-01866-2","journal-title":"Nat Neurosci"},{"key":"1864_CR95","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41593-024-01866-2","volume":"28","author":"X Yuan","year":"2025","unstructured":"Yuan X, Nie S, Yang Y, Liu C, Xia D, Meng L, Xia Y, Su H, Zhang C, Bu L, Deng M, Ye K, Xiong J, Chen L, Zhang Z (2025b) Propagation of pathologic \u03b1-synuclein from kidney to brain may contribute to Parkinson\u2019s disease. Nat Neurosci 28:577\u2013588. https:\/\/doi.org\/10.1038\/s41593-024-01866-2","journal-title":"Nat Neurosci"},{"key":"1864_CR97","doi-asserted-by":"publisher","first-page":"302","DOI":"10.20517\/jtgg.2024.39","volume":"8","author":"D Zhang","year":"2024","unstructured":"Zhang D, Xie K, Zhang J (2024) Fabry nephropathy: focus on podocyte damage and therapeutic target. J Transl Genet Genom 8:302\u2013311. https:\/\/doi.org\/10.20517\/jtgg.2024.39","journal-title":"J Transl Genet Genom"},{"issue":"3","key":"1864_CR96","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41593-024-01867-1","volume":"28","author":"Z Zhang","year":"2025","unstructured":"Zhang Z (2025) \u03b1-Synuclein deposition in the kidney may contribute to Parkinson\u2019s disease. Nat Neurosci 28(3):434\u2013435. https:\/\/doi.org\/10.1038\/s41593-024-01867-1","journal-title":"Nat Neurosci"},{"key":"1864_CR98","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.2174\/1570159x22666231103085859","volume":"22","author":"G Zhong","year":"2023","unstructured":"Zhong G, Wang X, Li J, Xie Z, Wu Q, Chen J, Wang Y, Chen Z, Cao X, Li T, Liu J, Wang Q (2023) Insights into the role of copper in neurodegenerative diseases and the therapeutic potential of natural compounds. Curr Neuropharmacol 22:1650. https:\/\/doi.org\/10.2174\/1570159x22666231103085859","journal-title":"Curr Neuropharmacol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01864-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01864-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01864-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:26:01Z","timestamp":1779161161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01864-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":98,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1864"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01864-2","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript does not contain any studies involving human participants or animals performed by any author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"This article does not contain any studies involving human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that AI tools, including ChatGPT and Grammarly, were used solely for language refinement, grammar correction, and formatting assistance. The scientific content, analysis, interpretations, and conclusions presented in this manuscript are entirely the authors\u2019 own responsibility.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Use of Artificial Intelligence (AI)"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}